key: cord-0037354-abj07quz
authors: Lee, Kyung Soo; Han, Joungho; Chung, Man Pyo; Jeong, Yeon Joo
title: Consolidation
date: 2013-08-22
journal: Radiology Illustrated: Chest Radiology
DOI: 10.1007/978-3-642-37096-0_22
sha: 35a17604a1656ab580c8ad13bb88c2cff6041a06
doc_id: 37354
cord_uid: abj07quz

Consolidation refers to an area of homogeneous increase in lung parenchymal attenuation that obscures the margins of vessels and airway walls [1]. Air bronchograms may be present with consolidative area. Pathologically, consolidation represents an exudate or other product of disease that replaces alveolar air, rendering the lung solid [2, 3].

Consolidation in COP is present alone or as part of a mixed pattern and has a predominantly subpleural or peribronchovascular distribution [ 4 ] . The consolidation usually involves both lungs and shows middle and lower lung zone predominance [ 5 , 6 ] . In CEP, CT scans show subpleural consolidation with upper and middle lung zone predominance [ 7 ] . Consolidation in CSS is present, usually mixed with other patterns of abnormalities including small nodules and ground-glass opacity (GGO), and shows random distribution [ 8 ] . Consolidation in radiation pneumonitis involves uniformly the irradiated lung portion, but not necessarily conforming to the shape of the irradiation portal [ 9 ] . The consolidation may show patchy and extensive distribution.

The presence of asthma history suggests the diagnosis of chronic eosinophilic lung disease (almost all patients in CSS and approximately 40 % of patients with CEP) [ 10 ] . COP or COP-like lung lesion may be seen in collagen vascular disease, occupational lung disease, or drug-induced lung disease. Abnormal lung lesions like consolidation occur equally in irradiated and unirradiated lung in radiation pneumonitis. This fact, along with prompt improvement of the lesions after corticosteroid therapy, suggests an immunologically mediated mechanism such as a hypersensitivity pneumonitis [ 11 ] . Also note some areas of ground-glass opacity ( arrows ) and poorly defi ned nodules ( arrowheads ). ( c ) Low-magnifi cation (×40) photomi-crograph of surgical lung biopsy specimen obtained from right upper lobe demonstrates alveolar-fi lling process with eosinophils ( arrows ).

( d ) High-magnifi cation (×100) photomicrograph discloses alveolar spaces fi lled with eosinophils (eosinophilic pneumonia) ( arrows ). In other areas, small extravascular granulomas and few areas of capillaritis were seen (not shown here)

COP is characterized by variably dense airspace aggregates of fi broblasts in immature collagen matrix. This alveolarfi lling process can be seen to extend into or from terminal bronchioles. Typically, the lung architecture is preserved in COP, and lymphocytes, plasma cells, and histiocytes are present in variable numbers within the interstitium ( Fig. 22 .1 ). Fibrin may be seen focally in association with airspace organization. Alveolar macrophage accumulation may be present, attesting to some degree of airway obstruction. Interstitial fi brosis and honeycomb lung remodeling are not components of the cryptogenic (idiopathic) form of organizing pneumonia [ 12 ] .

The initial manifestations are nonspecifi c, with a fl u-like illness of fever, malaise, and cough [ 13 ] . It is followed by progressive and usually mild dyspnea. Dyspnea may occasionally be severe. In most cases, the duration of onset is less than 3 months. The disease is frequently misdiagnosed as infectious pneumonia. Hemoptysis, chest pain, and night sweating are rare. Finger clubbing is absent. Bibasilar inspiratory crackles are observed at auscultation.

The characteristic HRCT fi nding of COP consists of unilateral or bilateral areas of airspace consolidation with subpleural or peribronchial distribution [ 4 , 14 ] ( Fig. 22.1 ). An air bronchogram with bronchial dilatation may be seen in patients who have extensive consolidation, and air bronchograms are usually restricted to these consolidative areas. GGOs are commonly present in association with the areas of consolidation. Curvilinear opacity with an arcade-like appearance (perilobular pattern) is seen in more than half of the patients [ 15 ] . Small, ill-defi ned nodules, often in a centrilobular distribution, are seen in 30-50 % of cases. Occasionally, the disease is manifested as a large nodule or mass-like area of consolidation. Sometimes, COP shows a reversed halo sign, which is defi ned as central GGO surrounded by more dense airspace consolidation with crescent and ring shapes [ 5 ] .

The areas of consolidation correspond histologically to the regions of lung parenchyma that show organizing pneumonia: granulation plugs lying within small airways, alveolar ducts, and alveoli [ 16 ] (Fig. 22 .1 ). The GGO correlates with areas of alveolar septal infl ammation and minimal airspace fi brosis. The small nodules are related to foci of organizing pneumonia limited to the peribronchial region or to fi broblastic tissue plugs within the bronchiolar lumen. Perilobular pattern pathologically refl ects the area of organizing exudate accumulation in the perilobular alveoli, with or without interlobular septal thickening [ 15 ] . Reversed halo sign correspond to central area of alveolar septal infl ammation and peripheral area of organizing pneumonia within the alveolar ducts [ 5 ] .

COP responds well to corticosteroids. Corticosteroids result in dramatic clinical improvement, with regression of symptoms within days. The overall prognosis is excellent. Spontaneous improvement over 3-6 months has been reported. Relapse occurs in 13-58 % of patients on decreasing or after stopping corticosteroid therapy.

Microscopically, eosinophils fi ll the alveoli and infi ltrate the interstitium ( Fig. 22 .2 ). The alveoli also contain a variable number of macrophages. The eosinophil infi ltrate may involve small blood vessels but necrotizing vasculitis is not encountered: its presence would suggest Churg-Strauss allergic granulomatosis [ 17 ] .

Cough and dyspnea are invariably present [ 18 ] . The severity of dyspnea is highly variable from one case to another.

Wheezing occurs in about half of the case. Chest pain and hemoptysis are rare. The symptoms are most often present for at least 1 month before diagnosis is made. Weight loss, night sweating, and fever are frequent. The most common extrathoracic manifestations are cardiac, including chest pain with ST segment changes or associated pericarditis.

The characteristic CT fi nding of CEP is non-segmental areas of airspace consolidation and GGO with peripheral predominance [ 19 , 20 ] (Fig. 22 .2 ). The consolidation and GGO usually have upper lobe predominance. Less common fi ndings include crazy-paving pattern, nodules, and reticulation. These less common fi ndings predominate in the later stages of CEP. CT performed more than 2 months after the onset of symptoms shows linear band-like areas of parenchymal opacity parallel to the pleural surface. Pleural effusion is observed in less than 10 % of cases.

Areas of consolidation on HRCT correspond histologically to accumulations of eosinophils and lymphocytes in the alveoli and interstitium and interstitial fi brosis ( Fig. 22 .2 ).

All the reports have confi rmed the dramatic response to corticosteroids. Symptoms and pulmonary infi ltrates on imaging improve within a few days of initiation of corticosteroid therapy. However, relapses are observed in up to 50 % of patients while tapering or after stopping the doses of corticosteroids. Long-term corticosteroid therapy is required in more than 50 % of the cases.

The fi ndings on lung biopsy depend on the stage of the disease during which the biopsy is obtained and whether or not the patient has received therapy, particularly steroids. Lung biopsies from CSS patients in the full blown vasculitic phase may show asthmatic bronchitis, eosinophilic pneumonia, extravascular stellate granulomas, and vasculitis ( Fig. 22. 3 ). Vasculitis can affect arteries, veins, or capillaries. Diffuse pulmonary hemorrhage and capillaritis can be seen [ 21 ] .

Mean age of onset is 38 years. Asthma is essentially universal in CSS [ 22 ] . Virtually all patients have eosinophilia. Cardiac involvement is relatively common and is a major cause of mortality. Compared with ANCA-associated granulomatous vasculitis and microscopic polyangiitis, peripheral nerve involvement is more common while pulmonary hemorrhage and glomerulonephritis are much less common.

The most common HRCT fi ndings consist of small centrilobular nodules, GGO, consolidation in a patchy or a predominantly subpleural distribution, bronchial wall thickening and dilatation, interlobular septal thickening, and a mosaic perfusion pattern [ 8 ] (Fig. 22.3 ) . Unilateral or bilateral pleural effusion is seen in up to 50 % of patients.

Small nodules histopathologically correlate with areas of dense eosinophilic and lymphocytic infi ltration in the bronchiolar walls and patchy areas of capillaritis in alveolar walls. The areas of consolidation correspond histopathologically to the area of eosinophilic or granulomatous infl ammation predominantly in the alveoli and alveolar walls. Interlobular septal thickening may be caused by septal edema, eosinophilic infi ltration, and mild fi brosis [ 8 , 23 ] .

Systemic corticosteroids remain the mainstay of therapy. Cyclophosphamide can be used in combination with corticosteroids in cases with severe disease. The mortality rates attributable to CSS or complications of therapy are less than 10-20 %. Older age, azotemia, and cardiac involvement are poor prognostic factors.

Microscopic fi ndings may include diffuse alveolar damage, acute interstitial pneumonia, and interstitial lymphocytic infi ltration in the early phase. There may be variable interstitial, alveolar, and replacement fi brosis in the late phase. Vascular intimal fi brosis with foamy macrophages can be seen [ 24 ] .

Symptoms of radiation pneumonitis, including low-grade fever, dry cough, pleuritic chest discomfort, sensation of chest fullness, and dyspnea, usually develop 1-3 months after completion of radiation therapy [ 25 ] . In severe cases, patients may present with respiratory failure. Hemoptysis is rare.

The hallmark of radiation pneumonitis on CT is the presence of increased lung attenuation corresponding closely to the location of irradiation ports (Fig. 22.4 ) . Increased lung attenuations include homogeneous GGO that uniformly involves the irradiated portions, patchy consolidation that is contained within the irradiated lung, or discrete consolidation that conforms to the shape of the radiation ports [ 9 , 26 ] . Subtle GGO or patchy consolidation can be detected outside of the radiation portal in 10-20 % of cases and is less severe than those seen within the radiation ports [ 9 ] .

Areas of GGO correspond histologically to airspace and interstitial edema and those of consolidation to diffuse alveolar damage.

Corticosteroids are the mainstay of therapy. It has been shown to improve symptoms and lung function. Signs and symptoms may recur after the cessation of the therapy. Supplemental oxygen may be necessary. Late pulmonary adverse effects include pulmonary fi brosis, which is permanent and associated with marked dyspnea.

Consolidation refers to an area of homogeneous increase in lung parenchymal attenuation that obscures the margins of vessels and airway walls [ 1 ] . Air bronchograms may be present with consolidative area (Repetition section " Ground-Glass Opacity without Reticulation, Subpleural and Patchy Distribution " in Chap. 21 ). In certain diseases, the areas of consolidation are widely spread or scattered (diffuse) throughout the lungs.

Extensive acute pneumonias including viral (Fig. 22 .

Pneumocystis pneumonia, acute interstitial pneumonia ( AIP ) (Figs. 22.6 and 22.7 ) or adult respiratory distress syndrome (ARDS), pulmonary edema, diffuse alveolar hemorrhage ( DAH ) (Fig. 22.8 ) show diffuse areas of consolidation in both lungs.

Although diffuse in distribution, subpleural lungs including apices and costophrenic angles may be spared in pulmonary edema and DAH. In Pneumocystis pneumonia, the parenchymal lesions may commence in the infrahilar regions and extend to the peripheral lungs. Parenchymal lesions in half of patients with AIP equally involve all three lung zones and those in 39 % of patients have lower lung zone predominance.

Viral pneumonia in adults can be classifi ed into two clinical groups: so-called atypical pneumonia in otherwise healthy hosts and viral pneumonia in immunocompromised hosts. [ 27 ] . AIP is a fulminant disease of unknown etiology, usually occurring in a previously healthy person and producing histologic fi ndings of diffuse alveolar damage (DAD) [ 28 ] . CT assessment is potentially helpful in predicting patient prognosis in AIP regardless of physiologic abnormality; namely in survivors, the extent of ground-glass opacity (GGO) or consolidation associated with traction bronchiolectasis or bronchiectasis was less and architectural distortion was also less frequent [ 29 ] .

ARDS, also called acute respiratory distress syndrome, is a type of lung failure that may result from any disease that causes large amounts of fl uid to collect in the lungs (DAD as in AIP). ARDS is not itself a specifi c disease, but a syndrome, a group of symptoms and signs that make up one of the most important forms of respiratory failure . As mentioned in a previous chapter, the most common underlying histology of DAH is of a small vessel vasculitis known as pulmonary capillaritis, usually seen with seropositive systemic vasculitides, or a connective tissue disorder (bland pulmonary hemorrhage), and DAD due to a number of injuries including, drugs, coagulation disorders and infection [ 30 ] . 

The microscopic fi ndings in most pulmonary viral infections include the direct effect of the virus as well as the host's infl ammatory response. The clinical outcome depends upon the virulence of the organism and the nature of the host response; and, consequent pathology includes DAD (Fig. 22.5 ) , diffuse or patchy bronchiolitis and interstitial pneumonitis, giant cell reactions, or even minimal change. The histopathologic diagnosis of viral infection is impossible without the identifi cation of the characteristic cytopathic effect (CPE). DAD, often with bronchiolitis, is the most typical pattern of viral lung injury. However, DAD also occurs in bacterial, mycobacterial, and fungal pneumonias; therefore, a careful search for specifi c viral CPE becomes important. For the surgical pathologist, CPE manifests mainly as the viral inclusion present in the nucleus or cytoplasm of an infected cell [ 31 ] .

In general, clinical manifestations of viral pneumonia are similar to those of bacterial pneumonia. However, wheezing and rhinorrhea are more common while viral pneumonia is less frequently febrile [ 32 ] . Mixed or superimposed infection of bacterial agents is common. Acute severe pneumonia progressing to ARDS in viral pneumonia has been increasingly reported.

On CT, viral pneumonia manifests as poorly defi ned centrilobular small nodules, GGO with a lobular distribution, and segmental consolidation. Because of the presence of associated cellular bronchiolitis, hyperinfl ation is commonly seen. With progression, the rapid confl uence of consolidation leads to DAD (Fig. 22 .5 ), consisting of homogeneous or patchy unilateral or bilateral airspace consolidation and GGO or poorly defi ned centrilobular nodules [ 27 ] .

CT fi ndings of viral pneumonia refl ect the variable extents of DAD (intra-alveolar edema, fi brin, and variable cellular infi ltrates with a hyaline membrane), intra-alveolar hemorrhage, and interstitial (intrapulmonary or airway) infl ammatory cell infi ltration (Fig. 22.5 ).

While therapy for most of viral pneumonia has not been fully clarifi ed, it is reasonable to assume antiviral agents may work if introduced early enough in the course of infection. Viral pneumonia presenting with ARDS requires mechanical ventilation and shows a mortality of 20-25 %.

Because AIP is idiopathic, other specifi c causes of acute lung injury must be excluded before making this diagnosis. Considerations in the differential diagnosis include infection, collagen vascular disease, acute exacerbation of idiopathic pulmonary fi brosis (IPF), drug effect, and other causes of DAD. Most cases of DAD are not AIP, and detailed clinical information, radiologic fi ndings, serologic data, and microbiologic results will often point to or rule out a specifi c etiologic condition. Use of special stains applied to tissue sections or cytologic preparations also is essential to rule out infectious organisms in this setting. AIP is characterized by the histologic pattern of DAD (Fig. 22.6 ). AIP cannot be distinguished from DAD on histology alone [ 33 ] .

AIP can affect patients of any age and sex. The disease if often preceded by a viral-like or fl u-like prodromal illness or upper respiratory tract infection characterized by fatigue and myalgia, followed by acute onset of dyspnea, fever and hypoxemia [ 34 ] . The duration of symptoms is usually less than 4-8 weeks. The patients have been previously healthy.

The early HRCT fi ndings of AIP consist of patchy or diffuse bilateral GGO and airspace consolidation with interlobular septal and intralobular interstitial thickening [ 28 , 35 ] ( Fig. 22.6 ) . Half of patients have no zonal predominance and 39 % of patients have lower lung zone predominance. With disease progression of disease, the GGO become diffuse, the areas of consolidation become more extensive, and architectural distortion and traction bronchiectasis become evident (Fig. 22.7 ) . Honeycombing is seen in a small percentage of patients.

Areas of GGO and consolidation without traction bronchiectasis occur in the exudative or early proliferative phase of AIP, whereas traction bronchiectasis is seen in the late proliferative and fi brotic phases of AIP [ 36 ] .

Honeycombing correlates with the presence of dense interstitial fi brosis and restructuring of distal airspaces.

There is no proven effective therapy. Virtually all patients require mechanical ventilation and supportive care. Many patients are treated with high-dose corticosteroids. The prognosis is poor. Overall, approximately half of patients die within 2 months. However, variable numbers of survivors have been reported [ 37 ] .

The histopathology of DAH is stereotypical ( Fig. 22.8 ) , regardless of etiology and a specifi c diagnosis requires clinical and serologic data. Most causes of DAH are immunologically mediated. Some of these diseases have specifi c patterns of immunoglobulin deposition that can be visualized in tissue sections by using immunofl uorescence staining of a specially prepared portion of the surgical lung biopsy. In practice today, immunofl uorescence staining is rarely necessary for diagnosis because serologic studies are widely available and reasonably specifi c for the subtypes of DAH [ 38 ] .

Patients with DAH present with cough, dyspnea, and hemoptysis [ 30 ] . In fact, one-third of patients will not have hemoptysis, despite active intra-alveolar bleeding. Fever and other systemic symptoms may be present, depending on the etiology of the diffuse alveolar hemorrhage. Careful attention should be given to the nasal and oropharyngeal examination to exclude clues to a vasculitis.

The most common CT features of DAH are bilateral GGOs and consolidation (Fig. 22.8 ) . The lesions are diffuse in the upper and lower lobes in approximately three-fourths of patients or are localized in the lower part of the lungs in 25 % of patients. Typically, the halo sign may be seen with parenchymal nodules or masses and consolidation on CT scans, representing the hemorrhagic nature of these parenchymal lesions. Smooth interlobular septal thickening becomes superimposed on areas of GGO (a crazy-paving appearance) within 2-3 days. These fi ndings may show improvement in the course of hemorrhage resorption.

Additionally, ill-defi ned centrilobular nodules may be present, refl ecting intra-alveolar accumulation of pulmonary macrophages. Nodules have been reported to be uniform in size (1-3 mm in diameter) and are diffusely distributed with no zonal predominance [ 39 ] .

The airspace lesions histopathologically correlate with pulmonary hemorrhage, both with or without capillaritis [ 40 ] ( Fig. 22.8 ).

The treatment of DAH depends on the underlying cause of hemorrhage. Corticosteroids are a mainstay of therapy in most cases. Cyclophosmide or azathioprine may be added. Plasmapheresis may be tried in the cases of the immune etiology. Mortality is considerable especially in small vessel vasculitis.

Parenchymal opacifi cation in chronic infi ltrative lung diseases: CT-pathologic correlation

High-resolution CT of alveolar fi lling disorders

Fleischner Society: glossary of terms for thoracic imaging

Cryptogenic organizing pneumonia: CT fi ndings in 43 patients

Reversed halo sign on highresolution CT of cryptogenic organizing pneumonia: diagnostic implications

Cryptogenic organizing pneumonia: serial high-resolution CT fi ndings in 22 patients

Chronic eosinophilic pneumonia: CT fi ndings in six cases

Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic fi ndings

Radiation-induced pulmonary change: CT fi ndings

The spectrum of eosinophilic lung disease: radiologic fi ndings

Radiation-induced lung injury: a hypersensitivity pneumonitis

Pathologic aspects of bronchiolitis obliterans organizing pneumonia

Cryptogenic organizing pneumonia

Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients

Organizing pneumonia: perilobular pattern at thin-section CT

High-resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia

Eosinophilic lung diseases

Idiopathic chronic eosinophilic pneumonia

Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients

Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview

Allergic granulomatosis (Churg-Strauss syndrome): pulmonary and renal morphologic fi ndings

Churg-Strauss syndrome

Churg-Strauss syndrome: high resolution CT and pathologic fi ndings

Radiation injury in surgical pathology. Part I

Radiation pulmonary toxicity: from mechanisms to management

CT appearance of acute radiation-induced injury in the lung

Viral pneumonias in adults: radiologic and pathologic fi ndings

Acute interstitial pneumonia: thin-section CT fi ndings in 36 patients

Acute interstitial pneumonia: comparison of high-resolution computed tomography fi ndings between survivors and nonsurvivors

Diffuse alveolar hemorrhage

Acute lower respiratory tract infection

Viruses associated with pneumonia in adults

Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study

Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fi brosis

Acute interstitial pneumonia: radiographic and CT fi ndings in nine patients

Acute interstitial pneumonia: high-resolution CT fi ndings correlated with pathology

Early intervention can improve clinical outcome of acute interstitial pneumonia

A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confi rmation

Imaging of pulmonary vasculitis

Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features